Two Cases of Generalized Morphea in Children

Nishinihon Journal of Dermatology

Volumn 59, Issue 6, 1997, Pages 820-825

  Kubota, Yumiko ^a   Koga, Tetsuya ^a   Toshitani, Shoji ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33646717233     PISSN: 03869784     EISSN: 18804047     Source Type: Journal    
DOI: 10.2336/nishinihonhifu.59.820     Document Type: Article

References (13)

1. Tuffanelli D.L., Winkelmann R.K.: Systemic scleroderma: a clinical study of 727 cases. Arch Dermatol 84: 359–371, 1961.
2. Rodnan G.P. et al: Eosinophilia and serologic abnormalities in linear localized scleroderma. Arthritis Rheum 20: 133,1977.
3. Falanga V., Medsger T.A. Jr., Reichlin M.: High titers of antibodies to single-stranded DNA in linear scleroderma. Arch Dermatol 121: 345–347, 1985.
4. Falanga V. et al: Linear scleroderma: clinical spectrum prognosis acid laboratory abnormalities. Ann Intern Med 104: 849–857, 1986.
5. Falanga V., Medsger T.A. Jr. Reichlin M.: Anti nuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea. Arch Dermatol 123: 350–353, 1987.
6. Takehara K. et al: Anti single-stranded DNA antibody and muscle involvement in localized scleroderma [letter]. Arch Dermatol 126: 1368–1369, 1990.
7. Ihn H. et al: Increased levels of circulating intercellular adhesion molecule-1 in patients with localized scleroderma. J Am Acad Dermatol 91: 591–595, 1994.
8. Ihn H. et al: Demonstration of interleukin 8 in serum samples of patients with localized scleroderma, Arch Dermatol 130: 1327–1328, 1994.
9. Joly P. et al: Treatment of severe forms of localized scleroderma with oral corticosteroids: Follow up study on 17 patients. Arch Dermatol 130: 663–664, 1994.
10. O'leary P.A. et al: Dermatohistopathology of various types of scleroderma. Arch Dermatol 75: 78–87, 1957.
11. Sato S. et al: Clinical characteristics associated with anti-histone antibodies in patients with localized scleroderma. J Am Acad Dermatol 31: 567–571, 1994.
12. Diaz-Perez J.L., Connolly S.M., Winkelmann R.K.: Disabling pansclerotic morphea. Arch Dermatol 116: 169–173, 1980.
13. Kachanek K.S. et al: PUVA therapy in disabling pansclerotic morphea of children. Br J Dermatol 132: 830–831, 1995.